Literatur
-
1
Arnesen T, Trommald M.
Roughly right or precisely wrong? Systematic review of quality-of-life weights elicited with the time trade-off method.
J Health Serv Res Policy.
2004;
9
43-50
-
2
Arnesen T, Trommald M.
Are QALYs based on time trade-off comparable? A systematic review of TTO methodologies.
Health Econ.
2005;
14
39-53
-
3
Bejia I, Salem K B, Touzi M, Bergaoui N.
Measuring utilities by the time trade-off method in Tunisian rheumatoid arthritis patients.
Clin Rheumatol.
2006;
25
38-41
-
4
Bleichrodt H, Pinto J L, Abellan-Perpinan J M.
A consistency test of the time trade-off.
J Health Econ.
2003;
22
1037-1052
-
5 Bleuler E. Das autistisch-undisziplinierte Denken in der Medizin und seine Überwindung. Nachdruck der 5. Auflage Springer, Heidelberg 1962
-
6
Brunner H I, Johnson A L, Barron A C. et al .
Gastrointestinal symptoms and their association with health-related quality of life of children with juvenile rheumatoid arthritis: validation of a gastrointestinal symptom questionnaire.
J Clin Rheumatol.
2005;
11
194-204
-
7
Burstrom K, Johannesson M, Diderichsen F.
A comparison of individual and social time trade-off values for health states in the general population.
Health Policy.
2006;
76
359-370
-
8
Coucill W, Bryan S, Bentham P, Buckley A, Laight A.
EQ-5D in patients with dementia: an investigation of inter-rater agreement.
Med Care.
2001;
39
760-771
-
9
Dolan P, Stalmeier P.
The validity of time trade-off values in calculating QALYs: constant proportional time trade-off versus the proportional heuristic.
J Health Econ.
2003;
22
445-458
-
10
Erling A, Wiklund I, Albertsson-Wikland K.
Prepubertal children with short stature have a different perception of their well-being and stature than their parents.
Qual Life Res.
1994;
3
425-429
-
11
Greiner W, Claes C, Busschbach J J, Graf von der Schulenburg J M.
Validating the EQ-5D with time trade off for the German population.
Eur J Health Econ.
2005;
6
124-130
-
12
Leidl R, Sintonen H, Abbühl B, Hoffmann C, von der Schulenburg J -M, König H H.
Do physicians accept quality of life and utility measurement?.
HEPAC.
2001;
2
170-175
-
13
Lobana A, Mattoo S K, Basu D, Gupta N.
Quality of life in schizophrenia in India: comparison of three approaches.
Acta Psychiatr Scand.
2001;
104
51-55
-
14
Maor Y, King M, Olmer L, Mozes B.
A comparison of three measures: the time trade-off technique, global health-related quality of life and the SF-36 in dialysis patients.
J Clin Epidemiol.
2001;
54
565-570
-
15
Martins S J, Ho N, Cavamura S O, Harada C M, Yamamoto C A, Takagaki T Y.
Lung cancer symptoms and pulse oximetry in the prognostic assessment of patients with lung cancer.
BMC Cancer.
2005;
5
72
-
16
Matza L S, Secnik K, Mannix S, Sallee F R.
Parent-proxy EQ-5D ratings of children with attention-deficit hyperactivity disorder in the US and the UK.
Pharmacoeconomics.
2005;
23
777-790
-
17
Matza L S, Secnik K, Rentz A M. et al .
Assessment of health state utilities for attention-deficit/hyperactivity disorder in children using parent proxy report.
Qual Life Res.
2005;
14
735-747
-
18
Mehrez A, Gafni A.
Evaluating health related quality of life: an indifference curve interpretation for the time trade-off technique.
Soc Sci Med.
1990;
31
1281-1283
-
19
Melsop K A, Boothroyd D B, Hlatky M A.
Quality of life and time trade-off utility measures in patients with coronary artery disease.
Am Heart J.
2003;
145
36-41
-
20
Milne D J, Mulder L L, Beelen H C, Schofield P, Kempen G I, Aranda S.
Patients’ self-report and family caregivers’ perception of quality of life in patients with advanced cancer: how do they compare?.
Eur J Cancer Care.
2006;
15
125-132
-
21
Naglie G, Tomlinson G, Tansey C. et al .
Utility-based Quality of Life measures in Alzheimer’s disease.
Qual Life Res.
2006;
15
631-643
-
22
Parsons S K, Barlow S E, Levy S L, Supran S E, Kaplan S H.
Health-related quality of life in pediatric bone marrow transplant survivors: according to whom?.
Int J Cancer Suppl.
1999;
12
46-51
-
23
Perez D J, McGee R, Campbell A V, Christensen E A, Williams S.
A comparison of time trade-off and quality of life measures in patients with advanced cancer.
Qual Life Res.
1997;
6
133-138
-
24
Pickard A S, Johnson J A, Feeny D H, Shuaib A, Carriere K C, Nasser A M.
Agreement between patient and proxy assessments of health-related quality of life after stroke using the EQ-5D and Health Utilities Index.
Stroke.
2004;
35
607-612
-
25
Pierre U, Wood-Dauphinee S, Korner-Bitensky N, Gayton D, Hanley J.
Proxy use of the Canadian SF-36 in rating health status of the disabled elderly.
J Clin Epidemiol.
1998;
51
983-990
-
26
Porzsolt F, Wölpl C, Rist C E, Kosa R, Büchele G, Gaus W.
Comparison of three instruments (QLQ-C30, SF-36, QWB-7) measuring health-related quality of life/quality of well being.
Psycho-Oncology.
1996;
5
103-117
-
27
Porzsolt F.
Ist die Messung der Lebensqualität möglich und notwendig? Warum Sie die Lebensqualität Ihrer Patienten messen sollten.
Der Allgemeinarzt.
1996;
18
610-624
-
28
Porzsolt F, Kilian R.
Klinische Forschung, Ergebnisforschung, Versorgungsforschung.
Gesundh ökon Qual manag.
2006;
11
311-318
-
29
Schwartz C E, Sprangers M A.
Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research.
Soc Sci Med.
1999;
48
1531-1548
-
30
Scocco P, Fantoni G, Caon F.
Role of depressive and cognitive status in self-reported evaluation of quality of life in older people: comparing proxy and physician perspectives.
Age Ageing.
2006;
35
166-171
-
31
Shiell A, Hawe P.
Test-retest reliability of willingness to pay.
Eur J Health Econ.
2006;
7
176-181
-
32
Sneeuw K C, Albertsen P C, Aaronson N K.
Comparison of patient and spouse assessments of health related quality of life in men with metastatic prostate cancer.
J Urol.
2001;
165
478-482
-
33
Sneeuw K C, Aaronson N K, de Haan R J, Limburg M.
Assessing quality of life after stroke. The value and limitations of proxy ratings.
Stroke.
1997;
28
1541-1549
-
34
Sterkenburg C A, King B, Woodward C A.
A reliability and validity study of the McMaster Quality of Life Scale (MQLS) for a palliative population.
J Palliat Care.
1996;
12
18-25
-
35
Tamim H, McCusker J, Dendukuri N.
Proxy reporting of quality of life using the EQ-5D. Proxy reporting of quality of life using the EQ-5D.
Med Care.
2002;
40
1186-1195
-
36
van der Pol M, Roux L.
Time preference bias in time trade-off.
Eur J Health Econ.
2005;
6
107-111
-
37
van Nooten F, Brouwer W.
The influence of subjective expectations about length and quality of life on time trade-off answers.
Health Econ.
2004;
13
819-823
-
38
von Plessen C, Bergman B, Andresen O. et al. for the Norwegian Lung Cancer Study Group .
Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer.
Brit J Cancer.
2006;
95
966-973
-
39 Weed L L. Das problemorientierte Krankenblatt. Year Book Medical Publishers, Inc. Chicago Schattauer 1978. Titel der Originalausgabe. Medical Records, Medical Education, and Patient Care 1971
Prof. Dr. Franz Porzsolt
Klinische Ökonomik, Universitätsklinikum Ulm
Frauensteige 6
89075 Ulm
